Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 21.18 0.57% 0.12
RXRX closed up 0.57 percent on Friday, May 14, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical RXRX trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.57%
Stochastic Buy Signal Bullish 0.57%
Spinning Top Other 0.57%
New 52 Week Low Weakness 0.57%
Multiple of Ten Bullish Other 0.57%
Older End-of-Day Signals for RXRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 11 hours ago
60 Minute Opening Range Breakout about 13 hours ago
Up 5% about 13 hours ago
Up 3% about 13 hours ago
Up 2% about 13 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Industry Health Sciences Drug Discovery Health Care Pharmaceutical Sciences Takeda Pharmaceutical Company Rare Monogenic Diseases

Is RXRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.78
52 Week Low 19.68
Average Volume 557,524
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 28.85
10-Day Moving Average 26.48
Average True Range 3.59
ADX 0.0
+DI 13.09
-DI 21.01
Chandelier Exit (Long, 3 ATRs ) 25.01
Chandelier Exit (Short, 3 ATRs ) 30.45
Upper Bollinger Band 37.50
Lower Bollinger Band 20.20
Percent B (%b) 0.06
BandWidth 59.93
MACD Line -3.25
MACD Signal Line -1.66
MACD Histogram -1.5929
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.68
Resistance 3 (R3) 24.68 23.51 24.09
Resistance 2 (R2) 23.51 22.62 23.51 23.90
Resistance 1 (R1) 22.35 22.07 21.77 22.35 23.70
Pivot Point 21.18 21.18 20.89 21.18 21.18
Support 1 (S1) 20.02 20.29 19.44 20.02 18.66
Support 2 (S2) 18.85 19.74 18.85 18.46
Support 3 (S3) 17.69 18.85 18.27
Support 4 (S4) 17.69